Business of Biotech 7.ppt

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * March-April 2009 * Constance McKee Constance McKee is currently founder, President CEO of Manzanita Pharmaceuticals, Inc 2007-present . Manzanita is the re-start of Asilomar Pharmaceuticals, Inc., an early-stage biotechnology company which filed for bankruptcy in June 2006. Manzanita is operating as a virtual company while seeking non-venture funding. Constance is currently involved in the following other consulting and bioentrepreneurial activities: Co-founder with Dr Jay Levy UCSF of California Antiviral Foundation, a start-up venture philanthropy to develop new therapies based on the CAF innate immune response in HIV/AIDS patients. Board member, co-founder and past President, BioE2E, Inc., , a 501 c 3 organization that has presented over 60 programs on topics of interest to bioentrepreneurs in the San Francisco Bay Area. From 1990-1994, Constance was Chief Executive of Cambridge Quantum Fund I, a seed venture fund investing in technologies from Cambridge University Cambridge, UK . From 1994-1995 she was co-founder and Chief Executive of SynGenix Limited, a portfolio investment of Cambridge Quantum Fund. From 1996-2001 she worked in the corporate venture capital group and in General Counsel’s office at Philips Semiconductors. From 2007-2008 she served as Co-Executive Director of Americans for Cures Foundation, a 501 c 3 organization dedicated to supporting advocates for stem cell research. In 1986-1987 she was a recipient of a Bosch Fellowship Bosch III which supported internships in corporate finance in Germany. She holds an MBA from Yale University School of Management, an MM from San Francisco Conservatory of Music voice and BA with distinction from Stanford University. Constance McKee Business of Biotech 7 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * March-April 2009 * Affymetrix AFFX Business Model Example: Research Tools Constance McKee Business of Bio